MetLife, Inc. vs Goldman Sachs Group, Inc. (The) — Stock Comparison
Q·Score Breakdown
6.1
Hold
Overall
6.9
Hold
Quality
Health
Growth
Valuation
Sentiment
MET
67% of 18 covering analysts rate it Buy or Strong Buy.
⚠ negative free cash flow.
GS
Earnings growing 24% year-over-year on 14% revenue growth.
⚠ cautious analyst consensus — few Buy ratings.
Analyst Consensus
BUY
Target $89.06 (+10.9%)
16 analysts
HOLD
Target $935.10 (+1.5%)
20 analysts
Fundamentals
MET
GS
17.1×
Trailing P/E
16.8×
7.3×
Forward P/E
14.1×
4.4%
Profit Margin
29.4%
23.4%
Gross Margin
82.3%
12.0%
ROE
14.6%
27.6%
Revenue Growth
14.5%
-34.2%
Earnings Growth
24.3%
0.73
Beta
1.31
—
Price / Book
—
$52.4B
Market Cap
$273.3B
$67 – $84
52-Week Range
$546 – $985
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load.